KEVIN HOLMES: Open Payments
NPI 1306871322 · PROVO, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$75 in 4 payments from 3 companies in 2025. Trend: 2023 $19 · 2024 $34 · 2025 $75
Food & beverage: $75
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 2 | $33 |
| Teva Pharmaceuticals USA, Inc. | 1 | $26 |
| Janssen Pharmaceuticals, Inc | 1 | $16 |
Products named: TRELEGY ELLIPTA, UZEDY, INVEGA SUSTENNA.
Industry payments across UT — which companies pay providers there.
